DeepMed Research

UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

NSAID Use After Robotic Partial Nephrectomy

Phase 2

Recruiting

Conditions: Renal Neoplasm
Renal Cancer
Kidney Cancer

Interventions: Drug: Ketorolac
Drug: Acetaminophen
Drug: Oxycodone
Drug: Hydromorphone
Drug: Ibuprofen

First Posted Date: 2023-05-03

Last Posted Date: 2024-10-08

Lead Sponsor: University of Miami

Target Recruit Count: 110

Registration Number: NCT05842044

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

Not Applicable

Recruiting

Conditions: Non Hodgkin Lymphoma
Hodgkin Lymphoma

Interventions: Behavioral: LIFE-L Mediterranean Diet
Behavioral: LIFE-L Home-Based Exercise Program
Behavioral: Supportive Materials

First Posted Date: 2023-05-03

Last Posted Date: 2025-04-20

Lead Sponsor: University of Miami

Target Recruit Count: 120

Registration Number: NCT05839210

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Virtual Reality for Youth Phobias

Not Applicable

Completed

Conditions: Specific Phobia
Autism Spectrum Disorder
Social Anxiety Disorder

Interventions: Behavioral: Virtual Reality for Youth Phobias

First Posted Date: 2023-05-03

Last Posted Date: 2024-07-19

Lead Sponsor: University of Miami

Target Recruit Count: 10

Registration Number: NCT05839431

Locations: 🇺🇸
University of Miami, Coral Gables, Florida, United States

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Phase 2

Recruiting

Conditions: Breast Cancer
ER-positive Breast Cancer
HER2-negative Breast Cancer
Metastatic Breast Cancer

Interventions: Drug: AI+CDK4/6i
Drug: SERD+CDK4/6i
Drug: mTOR inhibitor + AI
Drug: mTOR inhibitor + SERD
Drug: mTOR inhibitor + Selective estrogen receptor modulator
Drug: PI3K inhibitor + SERD
Drug: PI3K inhibitor + AI
Drug: Chemotherapy
Drug: Oral SERD

First Posted Date: 2023-04-24

Last Posted Date: 2024-07-23

Lead Sponsor: University of Miami

Target Recruit Count: 500

Registration Number: NCT05826964

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

The Impact of Respiratory Muscle Training and Patient Education on Chronic Constipation Outcomes

Not Applicable

Completed

Conditions: Constipation
Constipation - Functional
Dyssynergia

Interventions: Other: Standard Physical Therapy Care

First Posted Date: 2023-04-21

Last Posted Date: 2024-12-13

Lead Sponsor: University of Miami

Target Recruit Count: 28

Registration Number: NCT05823259

Locations: 🇺🇸
University of Miami, Coral Gables, Florida, United States

A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause

Phase 2

Recruiting

Conditions: Genitourinary Syndrome of Menopause
Breast Cancer

Interventions: Biological: Platelet-rich plasma (PRP)

First Posted Date: 2023-04-14

Last Posted Date: 2024-08-23

Lead Sponsor: University of Miami

Target Recruit Count: 20

Registration Number: NCT05812924

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease

Phase 4

Recruiting

Conditions: Genital Diseases, Male
Sexual Dysfunctions, Psychological
Peyronie Disease

Interventions: Drug: Collagenase Clostridium Histolyticum (CCH)

First Posted Date: 2023-03-20

Last Posted Date: 2025-01-24

Lead Sponsor: University of Miami

Target Recruit Count: 22

Registration Number: NCT05777031

Locations: 🇺🇸
University of Miami - Desai Sethi Urology Institute, Miami, Florida, United States
🇺🇸
University of Miami, Miami, Florida, United States

Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)

Phase 2

Completed

Conditions: Tetraplegia
Muscle Loss
Insulin Resistance
Paraplegia
Atrophy, Muscular
Spinal Cord Injuries

Interventions: Drug: Ursolic Acid
Other: Strength Training

First Posted Date: 2023-03-20

Last Posted Date: 2025-05-21

Lead Sponsor: University of Miami

Target Recruit Count: 10

Registration Number: NCT05776862

Locations: 🇺🇸
University of Miami - Miami Project to Cure Paralysis, Miami, Florida, United States

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Not Applicable

Recruiting

Conditions: Leukemia
Lymphoma
Myeloproliferative Neoplasm
Myeloma
Myelodysplastic Syndromes

Interventions: Other: LLS Program

First Posted Date: 2023-02-27

Last Posted Date: 2025-02-05

Lead Sponsor: University of Miami

Target Recruit Count: 400

Registration Number: NCT05745285

Locations: 🇺🇸
Sylvester Comprehensive Cancer Center, Miami, Florida, United States
🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
Mays Cancer Center at UT Health San Antonio, San Antonio, Texas, United States

The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury

Not Applicable

Recruiting

Conditions: Acute Spinal Cord Injury

Interventions: Device: Xcite Clinical Station

First Posted Date: 2023-02-27

Last Posted Date: 2024-07-03

Lead Sponsor: University of Miami

Target Recruit Count: 50

Registration Number: NCT05745298

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy